Anestezik Ajanların Farmakolojisi ve Klinik Etkileri

Hemmings HC, Egan TD. Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application. 2nd ed. Elsevier; 2019.

Evers AS, Maze M, Kharasch ED. Anesthetic Pharmacology: Basic Principles and Clinical Practice. 2nd ed. Cambridge University Press; 2011.

Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci. 2008;9(5):370-386.

Garcia PS, Kolesky SE, Jenkins A. General anesthetic actions on GABA(A) receptors. Curr Neuropharmacol. 2010;8(1):2-9.

Rudolph U, Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci. 2004;5(9):709-720.

Sleigh J, Harvey M, Voss L, Denny B. Ketamine – More mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care. 2014;4(2-3):76-81.

Patel AJ, Honoré E. Anesthetic-sensitive 2P domain K⁺ channels. Anesthesiology. 2001;95(4):1013-1021.

Shafer SL, Gregg KM. Algorithms to rapidly achieve and maintain stable drug concentrations at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharm. 1992;20(2):147-169.

Wagner JG. Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and man. J Theor Biol. 1968;20(2):173-201.

Eger EI 2nd, MacLeod BA. Anaesthesia: A continuum or a switch? A study of the dose-response curves for propofol and isoflurane in mice. Anesthesiology. 1995;83(5):1063-1067.

Kenakin TP. A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery. 4th ed. Academic Press; 2014.

Neubig RR, Spedding M, Kenakin T, Christopoulos A. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev. 2003;55(4):597-606.

Miller RD, Cohen NH, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL. Miller's Anesthesia. 8th ed. Elsevier Saunders; 2015.

Stoelting RK, Hillier SC. Pharmacology and Physiology in Anesthetic Practice. 4th ed. Lippincott Williams & Wilkins; 2006.

Eger EI 2nd, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology. 1965;26(6):756-763.

Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med. 2003;348(21):2110-2124.

Gaumann RS, Mustaki JP, Tassonyi E. Minimum alveolar konsantrasyon-awake of isoflurane, enflurane and halothane evaluated by slow and fast alveolar washout. Br J Anaesth. 1992;68(1):81-84.

Roizen MF, Horrigan RW, Frazer BM. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision--Minimum alveolar konsantrasyon BAR. Anesthesiology. 1981;54(5):390-398.

Quasha AL, Eger EI 2nd, Tinker JH. Determination and applications of Minimum alveolar konsantrasyon. Anesthesiology. 1980;53(4):315-334.

Babad AA, Eger EI 2nd. The effects of hyperthyroidism and hypothyroidism on halothane and oxygen requirements in dogs. Anesthesiology. 1968;29(6):1087-1093.

Deng J, Lei C, Chen Y, at all. Neuroprotective gases--fantasy or reality for clinical use? Prog Neurobiol. 2014;115:210-45.

Brown EN, Pavone KJ, Naranjo M. Multimodal General Anesthesia: Theory and Practice. Anesth Analg. 2018;127(5):1246-1258.

Aranake A, Mashour GA, Avidan MS. Minimum alveolar concentration: ongoing relevance and clinical utility. Anaesthesia. 2013;68(5):512-22.

Brosnan RJ. Inhaled anesthetics in horses. Vet Clin North Am Equine Pract. 2013;29(1):69-87.

Scheiermann P, Herzog F, Siebenhofer A, at all. Intravenous versus inhalational anesthesia for pediatric inpatient surgery - A systematic review and meta-analysis. J Clin Anesth. 2018;49:1925.

Hopkins PM, Gupta PK, Bilmen JG. Malignant hyperthermia. Handb Clin Neurol. 2018;157:645-661.

Rosenberg H, Pollock N, Schiemann A, at all. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015-04;10:93.

Voulgarelis S, Scott JP. Monitoring for Nonoperating Room Anesthesia. Anesthesiol Clin. 2017;35(4):591-599.

Finger RG, Mallmann C, Nedel WL. BIS monitoring in sedated, mechanically ventilated patients: right tool in the wrong patients? A meta-analysis. Intensive Care Med. 2016;42(6):1086-7. [PubMed]

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. NaGüncel Anesteziyoloji ve Ağrı Çalışmaları V - 136 - National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda (MD): Jan 1, 2018.

Halothane Anesthetics.

Dayan AD. Analgesic use of inhaled methoxyflurane: Evaluation of its potential nephrotoxicity. Hum Exp Toxicol. 2016;35(1):91-100.

Ong Sio LCL, Dela Cruz RGC, Bautista AF. Sevoflurane and renal function: a meta-analysis of randomized trials. Med Gas Res. 2017;7(3):186-193.

Kapoor MC, Vakamudi M. Desflurane - revisited. J Anaesthesiol Clin Pharmacol. 2012;28(1):92- 100.

Ankar A, Kumar A. Vitamin B12 deficiency. StatPearls [Internet]. 2021.

Olutoye OA, Sheikh F, Zamora IJ, at all. Repeated isoflurane exposure and neuroapoptosis in the midgestation fetal sheep brain. Am J Obstet Gynecol. 2016;214(4):542.e1-542.e8.

Esencan E, Yuksel S, Tosun YB, at all. XENON in medical area: emphasis on neuroprotection in hypoxia and anesthesia. Med Gas Res. 2013;3(1):4.

Jin Z, Piazza O, Ma D, at all. Xenon anesthesia and beyond: pros and cons. Minerva Anestesiol. 2019;85(1):83-89.

Neukirchen M, Hipp J, Schaefer MS, at all. Cardiovascular stability and unchanged muscle sympathetic activity during xenon anaesthesia: role of norepinephrine uptake inhibition. Br J Anaesth. 2012;109(6):88796.

Rylova A, Maze M. Protecting the Brain With Xenon Anesthesia for Neurosurgical Procedures. J Neurosurg Anesthesiol. 2019;31(1):18-29.

Jia P, Teng J, Zou J, at all. Xenon Protects Against Septic Acute Kidney Injury via miR-21 Target Signaling Pathway. Crit Care Med. 2015;43(7):e250-9.

Baur CP, Klingler W, Jurkat-Rott K, at all. Xenon does not induce contracture in human malignant hyperthermia muscle. Br J Anaesth. 2000;85(5):712-6.

Goto T, Saito H, Nakata Y, at all. Emergence times from xenon anaesthesia are independent of the duration of anaesthesia. Br J Anaesth. 1997;79(5):595-9.

Law LS, Lo EA, Gan TJ. Xenon Anesthesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Anesth Analg. 2016;122(3):678-697.

Hou B, Li F, Ou S, at all. Comparison of recovery parameters for xenon versus other inhalation anesthetics: systematic review and meta-analysis. J Clin Anesth. 2016;29:65-74.

Kelen D, Robertson NJ. Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev. 2010;86(6):369-77.

Lachmann B, Armbruster S, Schairer W, at all. Safety and efficacy of xenon in routine use as an inhalational anaesthetic. Lancet. 1990;335(8703):1413-5.

Mapleson WW. Effect of age on Minimum alveolar konsantrasyon in humans: a meta-analysis. Br J Anaesth. 1996;76(2):179-85.

Al Tmimi L, Verbrugghe P, Van de Velde M, at all. Intraoperative xenon for prevention of delirium after on-pump cardiac surgery: a randomised, observer-blind, controlled clinical trial. Br J Anaesth. 2020;28.

Schaefer MS, Treschan TA, Gauch J, at all. Influence of xenon on pulmonary mechanics and lung aeration in patients with healthy lungs. Br J Anaesth. 2018 Jun;120(6):1394-1400. [Pub- Med]

Coburn M, Kunitz O, Baumert JH, at all. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth. 2005;94(2):198-202.

Kayhan Z: Klinik Anestezi. Logos Yayıncılık 2004, 99-123

Morgan EG, Mikhail SM, Murray SM: Klinik Anesteziyoloji: Nonvolatil anestezik ajanlar. Günes Kitapevleri, 2008; 8, 179-204

Aitkenhead AR, Rowbotham DJ, Smith G. Textbook of Anaesthesia, 4th ed., Churchill Livingstone, 2001, P:223-235

Morgan GE, Mikhail MS, Murray MJ, Larsson CP. Clinical Anesthesiology, 3rd ed., McGraw-Hill, 2002, P:178-206

Miller RD: Anesthesia, 4th ed., Churchill Livingstone, 1994, P: 417-488 ve 731-754.

Miller RD. Suggammadex: An opportunity to change the practice in anesthesiology? Anesth Analg 2007; 104; 477-478.

Diefenbach C (1998). Anestezi ve Cerrahi girişim sırasında nöromüsküler monitorizasyon. Urban&Schwarzenberg. 2. Baskı.

Christie TH, Churchill-Davidson HC. The St. Thomas’s Hospital nevre stimulator in the diagnosis of prolonged apnoea. Lancet 1958; 1: 776.

A new way to monitor paralyzing drugs. RN/MCPHU Home Study Program. http://www.rnweb.com/ce/0500/paralyze.html

Viby-Mogensen J. (2000) Neuromuscular monitoring. In: Anesthesia. Ed. By: Miller RD. Fifth Edition. Vol I. P: 1351.

Drenck NE, Ueda N, Olsen NV, et al. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology 1989; 70: 578-581.

Gill SS, Donati F, Bevan DR. Clinical evaluation of double-burst stimulation. Its relationship to train-of-four stimulation. Anaesthesia 1990; 45: 543-548.

Brull SJ, Silverman DG. Visual and tactile assessment of neuromuscular fade. Anesth Analg 1993; 77: 352-355.

Becker DE, Reed KL. Essentials of local anesthetic pharmacology. Anesth Prog. 2006;53(3):98-108.

Butterworth JF 4th, Strichartz GR. Molecular mechanisms of local anesthesia: a review. Anesthesiology. 1990;72(4):711-34.

Heavner JE. Local anesthetics. Curr Opin Anaesthesiol. 2007;20(4):336-42.

Catterall WA, Mackie K. Local Anesthetics. In: Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th ed. McGraw-Hill; 2017.

Arthur GR. Pharmacokinetics of local anesthetics. Handb Exp Pharmacol. 1990;97:165-86.

McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anestesiol. 2005;71(3):59-74.

Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol. 1977;69(4):497-515.

Strichartz G. Molecular mechanisms of nerve block by local anesthetics. Anesthesiology. 1976;45(4):421-41.

Ragsdale DS, et al. Molecular determinants of state-dependent block of Na⁺ channels by local anesthetics. Science. 1994;265(5179):1724-8.

Courtney KR. Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA 968. J Pharmacol Exp Ther. 1975;195(2):225-36.

Nau C, Wang GK. Interactions of local anesthetics with voltage-gated Na⁺ channels. J Membr Biol. 2004;201(1):1-8.

75.Hollmann MW, Durieux ME. Local anesthetics and the inflammatory response: a new therapeutic indication? Anesthesiology. 2000;93(3):858-75.

Malamed SF. Handbook of Local Anesthesia. 7th ed. Elsevier; 2019.

Bernards CM. Epidural and spinal anesthesia. In: Barash PG, et al. Clinical Anesthesia. 8th ed. Wolters Kluwer; 2017.

Bhole MV, et al. IgE-mediated allergy to local anaesthetics: separating fact from perception: a UK perspective. Br J Anaesth. 2012;108(6):903-11.

Friedman PM, et al. Topical anesthetics in dermatology. J Am Acad Dermatol. 2001;45(2):205-16.

Chahar P, Cummings KC 3rd. Liposomal bupivacaine: a review of a new bupivacaine formulation. J Pain Res. 2012;5:257-64.

Gasser HS, Erlanger J. The role of fiber size in the establishment of a nerve block by pressure or cocaine. Am J Physiol. 1929;88:581-591.

Zink W, Graf BM. The toxicity of local anesthetics: the place of ropivacaine and levobupivacaine. Curr Opin Anaesthesiol. 2008;21(5):645-50.

Marhofer P, et al. Ultrasonographic guidance in regional anaesthesia. Br J Anaesth. 2010;104(6):673-83.

McClure JH. Ropivacaine. Br J Anaesth. 1996;76(2):300-7.

Guay J. Adverse events associated with intravenous regional anesthesia (Bier block): a systematic review of complications. J Clin Anesth. 2009;21(8):585-94.

Neal JM, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35(2):152-61.

Groban L. Central nervous system and cardiovascular effects of local anesthetics. Reg Anesth Pain Med. 2003;28(1):3-11.

Weinberg GL. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med. 2010;35(2):188-93.

Thyssen JP, et al. The epidemiology of contact allergy to anesthetics. Contact Dermatitis. 2008;59(4):215-22.

Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesth Analg. 2009;108(3):837-45.

Sinnott CJ, et al. On the mechanism by which epinephrine potentiates lidocaine's peripheral nerve block. Anesthesiology. 2003;98(1):181-8.

Oda Y, et al. The involvement of human cytochrome P450 3A4 and 1A2 in the metabolism of ropivacaine. Anesth Analg. 1998;86(4):800-5.

Tucker GT, Mather LE. Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokinet. 1979;4(4):241-78.

Brummett CM, et al. Dexmedetomidine added to ropivacaine causes a dose-dependent increase in the duration of thermal antinociception in sciatic nerve block in rat. Anesthesiology. 2009;111(5):1111-9.

Covino BG. Pharmacology of local anaesthetic agents. Br J Anaesth. 1986;58(7):701-16.

Vincent, J. L., & De Backer, D. (2013). Circulatory shock. New England Journal of Medicine, 369(18), 1726-1734.

Gan, T. J., et al. (2020). Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesthesia & Analgesia, 131(2), 411-448.

Charbit, B., et al. (2005). Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology, 103(6), 1154-1159.

De Oliveira, G. S., et al. (2013). Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesthesia & Analgesia, 116(1), 58-74.

Schaub, I., et al. (2012). Droperidol for the prevention of postoperative nausea and vomiting. European Journal of Anaesthesiology, 29(6), 286-291.

Vallejo, M. C., et al. (2012). Aprepitant plus ondansetron compared with ondansetron alone in reducing postoperative nausea and vomiting in ambulatory patients. Journal of Clinical Anesthesia, 24(1), 15-21.

Mirakhur, R. K. (1988). Anticholinergic drugs in anaesthesia: a survey of current practice. Anaesthesia, 43(11), 940-942.

Tune, L. E. (2001). Anticholinergic effects of medication in elderly patients. The Journal of Clinical Psychiatry, 62(Suppl 21), 11-14.

Ali-Melkkilä, T., Kanto, J., & Iisalo, E. (1993). Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiologica Scandinavica, 37(7), 633-642.

Wildiers, H., & Menten, J. (2002). Death rattle: prevalence, prevention and treatment. Journal of Pain and Symptom Management, 23(4), 310-317.

Kamibayashi, T., & Maze, M. (2000). Clinical uses of alpha_2-adrenergic agonists. Anesthesiology, 93(5), 1345-1349.

Riker, R. R., et al. (2009). Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA, 301(5), 489-499.

Ebert, T. J., et al. (2000). The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology, 93(2), 382-394.

Giovannitti Jr, J. A., Thoms, S. M., & Crawford, J. J. (2015). Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesthesia Progress, 62(1), 31-39.

Overgaard, C. B., & Dzavík, V. (2008). Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation, 118(10), 1047-1056.

Evans, L., et al. (2021). Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine, 47(11), 1181-1247.

Levy, B., et al. (2011). Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. Journal of the American College of Cardiology, 58(2), 213-220.

Russell, J. A., et al. (2008). Vasopressin versus norepinephrine infusion in patients with septic shock. New England Journal of Medicine, 358(9), 877-887.

Thiele, R. H., et al. (2011). Management of the hemodynamically unstable patient with hypertrophic cardiomyopathy. Journal of Cardiothoracic and Vascular Anesthesia, 25(6), 1134-1144.

De Backer, D., et al. (2010). Comparison of dopamine and norepinephrine in the treatment of shock. New England Journal of Medicine, 362(9), 779-789.

Evers, A. S., & Maze, M. (2025). Anesthetic Pharmacology: Basic Principles and Clinical Practice (6th ed.). Cambridge University Press.

Chestnut, D. H., Wong, C. A., Tsen, L. C., et al. (2024). Chestnut's Obstetric Anesthesia: Principles and Practice (7th ed.). Elsevier.

Birch, M., & Hughes, E. (2022). Pharmacokinetics in pregnancy. BJA Education, 22(5), 154-160.

Palahniuk, R. J., Shnider, S. M., & Eger, E. I. (2021). Pregnancy decreases the requirement for inhaled anesthetic agents. Anesthesiology, 134(2), 241-255.

Kuczkowski, K. M. (2023). Respiratory changes in pregnancy and their implications for anesthesia. Acta Anaesthesiologica Scandinavica, 67(8), 988-995.

D'Angelo, R., & Smiley, R. M. (2020). Epidural and spinal anesthesia for labor and delivery. Clinics in Perinatology, 47(3), 425-442.

Datta, S., Lambert, D. H., Gregus, J., et al. (1983). Differential sensitivities of mammalian nerve fibers during pregnancy. Anesthesia & Analgesia, 62(12), 1070-1072. (Klasik referans)

Mazoit, J. X., & Dalens, B. J. (2018). Pharmacokinetics of local anaesthetics in infants and children and pregnancy. Clinical Pharmacokinetics, 57(9), 1145-1156.

Davis, P. J., & Cladis, F. P. (2021). Smith's Anesthesia for Infants and Children (10th ed.). Elsevier.

Anderson, B. J., & Holford, N. H. (2019). Mechanism-based concepts of size and maturity in pharmacokinetics. Annual Review of Pharmacology and Toxicology, 53, 315-336.

Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., et al. (2018). Developmental pharmacology—drug disposition, action, and therapy in infants and children. New England Journal of Medicine, 349(12), 1157-1167.

Rigby-Jones, A. E., & Sneyd, J. R. (2022). Pharmacokinetics and pharmacodynamics in paediatric anaesthesia. Continuing Education in Anaesthesia Critical Care & Pain, 12(4), 185-190.

Lerman, J. (2020). Inhalational agents in pediatric anesthesia. Paediatric Anaesthesia, 30(2), 116-123.

Ledeur, T., & Lerman, J. (2021). Minimum alveolar concentration of inhaled anesthetics in children. Anesthesiology, 135(4), 682-691.

Sieber, F. E., & Pauldine, R. (2024). Geriatric anesthesia. In Miller's Anesthesia (10th ed., pp. 2235-2250). Elsevier.

Turnheim, K. (2018). When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Experimental Gerontology, 38(8), 843-853.

Kanonidou, Z., & Karystianou, G. (2019). Anesthesia for the elderly. Hippokratia, 11(4), 175-177.

Eilers, H., & Kampmeyer, T. (2022). Cardiovascular physiology and pathophysiology in the elderly: implications for anesthesia. Anesthesiology Clinics, 40(4), 605-618.

Mapleson, W. W. (1996). Effect of age on Minimum alveolar konsantrasyon in humans: a meta-analysis. British Journal of Anaesthesia, 76(2), 179-185. (Kılavuz referans)

Vuyk, J. (2023). Pharmacodynamics in the elderly. Best Practice & Research Clinical Anaesthesiology, 37(1), 5-15.

Priebe, H. J. (2020). Liver disease and anesthesia. In Barash Clinical Anesthesia (9th ed., pp. 1250-1280). Wolters Kluwer.

Verbeeck, R. K. (2018). Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. European Journal of Clinical Pharmacology, 64(12), 1147-1161.

Delcò, F., Tchambaz, L., Schlienger, R., et al. (2021). Dose adjustment in patients with liver disease. Drug Safety, 28(6), 529-545.

Blei, A. T., & Córdoba, J. (2022). Hepatic encephalopathy. American Journal of Gastroenterology, 96(7), 1968-1976.

Hunter, J. M. (2019). New neuromuscular blocking drugs. New England Journal of Medicine, 332(25), 1691-1699.

Osborne, R., Joel, S., Trew, D., & Slevin, M. (2020). Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clinical Pharmacology & Therapeutics, 47(1), 12-19.

Latta, K. S., Ginsberg, B., & Barkin, R. L. (2022). Meperidine: a critical review. American Journal of Therapeutics, 9(1), 53-68.

Slutsky, J. (2024). Anesthesia for the patient with renal disease. In Stoelting's Pharmacology & Physiology in Anesthetic Practice (7th ed.). Wolters Kluwer.

Thomsen, J. L., & Martinsen, A. M. (2021). Hyperkalaemia and succinylcholine: a review. Acta Anaesthesiologica Scandinavica, 65(7), 890-896.

Adams, D. R., & Tollinche, L. E. (2023). The use of sugammadex in patients with end-stage renal disease. Anesthesia & Analgesia, 136(3), 481-489.

Hines, R. L., & Marschall, K. E. (2018). Stoelting's Anesthesia and Co-Existing Disease. Elsevier Health Sciences.

Evers, A. S., Maze, M., & Kharasch, E. D. (2011). Anesthetic Pharmacology: Basic Principles and Clinical Practice. Cambridge University Press.

Hemmings, H. C., & Egan, T. D. (2018). Pharmacology and Physiology for Anesthesia. Elsevier.

Butterworth, J. F., Mackey, D. C., & Wasnick, J. D. (2018). Morgan and Mikhail's Clinical Anesthesiology. McGraw-Hill Education.

Kennedy, J. M., et al. (2020). "Protein binding of anesthetics and analgesics in the perioperative period," Journal of Anesthesia, 34(2), 256-267.

Haining, R. L. (2017). "Cytochrome P450 and anesthesia," Anesthesiology Clinics, 35(2), 283-294.

Eyler, R. F., & Mueller, B. A. (2019). "Antibiotic pharmacokinetic and pharmacodynamic considerations in the perioperative period," Surgical Infections, 20(8), 589-596.

Völler, K., et al. (2021). "Pharmacokinetics of analgesics in patients with renal impairment," European Journal of Anaesthesiology, 38(1), 12-25.

Miller, R. D., et al. (2020). Miller's Anesthesia, 9th Edition. Elsevier.

Eikermann, M., et al. (2018). "Interactions between volatile anesthetics and neuromuscular blocking agents," Acta Anaesthesiologica Scandinavica, 62(5), 586-595.

Macintyre, P. E., et al. (2014). Acute Pain Management: Scientific Evidence. ANZCA.

Kaye, A. D., et al. (2020). "Buprenorphine and perioperative pain management," Anesthesiology, 132(6), 1580-1594.

Roshanov, P. S., et al. (2017). "Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery," Anesthesiology, 126(1), 16-27.

Fleisher, L. A., et al. (2014). "2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery," Circulation, 130(24), e278-e333.

Devereaux, P. J., et al. (2014). "Perioperative medication management," New England Journal of Medicine, 370(18), 1764-1773.

Peck, T., & Hill, S. A. (2014). Pharmacology for Anaesthesia and Intensive Care. Cambridge University Press.

Auer, P. (2019). "Serotonin syndrome in the perioperative period," BJA Education, 19(5), 143-148.

Horlocker, T. T., et al. (2018). "Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy," Regional Anesthesia & Pain Medicine, 43(3), 263-309.

Gogarten, W., et al. (2010). "European Society of Anaesthesiology guidelines for regional anaesthesia in patients on antithrombotic drugs," European Journal of Anaesthesiology, 27(12), 999-1015.

Ang-Lee, M. K., Moss, J., & Yuan, C. S. (2001). "Herbal medicines and perioperative care," JAMA, 286(2), 208-216.

Ljungqvist, O., Scott, M., & Fearon, K. C. (2017). "Enhanced Recovery After Surgery: A review," JAMA Surgery, 152(3), 292-298.

Murphy, G. S. (2018). "Neuromuscular monitoring in the perioperative period," Anesthesia & Analgesia, 126(2), 464-468.

Chou, R., et al. (2016). "Management of Postoperative Pain: A Clinical Practice Guideline," The Journal of Pain, 17(2), 131-157.

Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006). Pharmacogenomics and individualized drug therapy. Annual Review of Medicine, 57, 119-137.

Lurati Buse, G. A., & Luginbühl, M. (2010). Butyrylcholinesterase deficiency: a comprehensive review. British Journal of Anaesthesia, 105(5), 585-594.

Rosenberg, H., Pollock, N., Schiemann, A., Bulger, T., & Stowell, K. (2015). Malignant hyperthermia: a review. Orphanet Journal of Rare Diseases, 10(1), 98.

Crews, K. R., Gaedigk, A., Dunnenberger, H. M., et al. (2012). Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy. Clinical Pharmacology & Therapeutics, 91(2), 321-326.

Hwang, I. C., Park, J. Y., Myung, N. M., et al. (2014). OPRM1 A118G gene variant and postoperative opioid requirement: a systematic review and meta-analysis. Anesthesiology, 121(4), 825-834.

Kurosaka, Y., Ishii, K., Kamiya, C., & Obata, Y. (2018). Pharmacogenomics in anesthesia: an update. Journal of Anesthesia, 32(4), 540-549.